Tianjin Chase Sun Pharmaceutical Co.,Ltd (SHE:300026)

China flag China · Delayed Price · Currency is CNY
3.610
+0.040 (1.12%)
At close: Feb 3, 2026
3.74%
Market Cap10.84B -6.2%
Revenue (ttm)5.49B -2.4%
Net Income-66.13M
EPS-0.03
Shares Out3.00B
PE Ration/a
Forward PEn/a
Dividend0.03 (0.84%)
Ex-Dividend DateJun 24, 2025
Volume26,732,672
Average Volume49,913,514
Open3.590
Previous Close3.570
Day's Range3.580 - 3.630
52-Week Range3.080 - 4.490
Beta0.06
RSI45.99
Earnings DateApr 21, 2026

About SHE:300026

Tianjin Chase Sun Pharmaceutical Co.,Ltd engages in the research and development, production, and sale of various pharmaceutical products in China and internationally. The company provides Chinese medicine formula granules, finished drugs, raw materials, medical devices and excipients, medical and health services, as well as smart supply chain for pharmaceuticals and medical devices. It serves the fields of immunity, cardiovascular and cerebrovascular diseases, respiratory system, and neurodegenerative diseases. The company was founded in 1996 ... [Read more]

Sector Healthcare
Founded 1996
Employees 5,297
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300026
Full Company Profile

Financial Performance

In 2024, SHE:300026's revenue was 5.78 billion, a decrease of -5.34% compared to the previous year's 6.11 billion. Earnings were 21.47 million, a decrease of -95.76%.

Financial Statements